This video was made by McMaster Demystifying Medicine students Kavena Sivakumar, Alice Nassar, Halla Rahman, Waleed Dhillon & Elise MacLean
Copyright McMaster University 2017
Please let us know how you liked this video and suggest additional topics for us to demystify below.
References:
Hillig, K. W., & Mahlberg, P. G. (2004). A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany, 91(6), 966-975.
Prevalence and correlates of marijuana use in Canada, 2012. (2015, November 27). Retrieved February 12, 2017, from HYPERLINK “http://www.statcan.gc.ca/pub/82-003-x/2015004/article/14158-eng.htm” http://www.statcan.gc.ca/pub/82-003-x/2015004/article/14158-eng.htm
=Ilan, A. B., Gevins, A., Coleman, M., ElSohly, M. A., & De Wit, H. (2005). Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids. Behavioural pharmacology, 16(5-6), 487-496.
Burgdorf, J. R., Kilmer, B., & Pacula, R. L. (2011). Heterogeneity in the composition of marijuana seized in California. Drug and alcohol dependence, 117(1), 59-61.
Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. S. (2012). Interaction between cannabidiol (CBD) and∆ 9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids. Psychopharmacology, 219(1), 247-249.
Anderson, L. C. (1980). Leaf variation among Cannabis species from a controlled garden. Botanical Museum Leaflets, Harvard University, 28(1), 61-69.
Hillig, K. W., & Mahlberg, P. G. (2004). A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany, 91(6), 966-975.
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimaraes, F. S. (2006). Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Brazilian Journal of Medical and Biological Research, 39(4), 421-429.
Kogan, N. M., & Mechoulam, R. (2007). Cannabinoids in health and disease. Dialogues in clinical neuroscience, 9(4), 413.
Jay, C., Shade, S., Vizoso, H., Reda, H., Petersen, K., Rowbotham, M., & Abrams, D. (2004). The effect of smoked marijuana on chronic neuropathic and experimentally induced pain in HIV neuropathy: Results of an open-label pilot study. University of California, San Francisco: February, 8-11.
Machado Rocha, F. C., Stefano, S. C., De Cassia Haiek, R., Rosa Oliveira, L. M. Q., & Da Silveira, D. X. (2008). Therapeutic use of Cannabis sativa on chemotherapy‐induced nausea and vomiting among cancer patients: systematic review and meta‐analysis. European journal of cancer care, 17(5), 431-443.
Campbell, F. A., Tramèr, M. R., Carroll, D., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001). Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. Bmj, 323(7303), 13.
Koppel, B. S., Brust, J. C., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., & Gloss, D. (2014). Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82(17), 1556-1563.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370(23), 2219-2227.
Zalesky, A., Solowij, N., Yücel, M., Lubman, D. I., Takagi, M., Harding, I. H., … & Seal, M. (2012). Effect of long-term cannabis use on axonal fibre connectivity. Brain, 135(7), 2245-2255.
Tashkin, D. P. (2013). Effects of marijuana smoking on the lung. Annals of the American Thoracic Society, 10(3), 239-247.
